Skip to main content
. 2021 Sep 8;21:340. doi: 10.1186/s12893-021-01337-6

Table 3.

Differentiating neuroendocrine tumors with immunohistochemical markers

Immunohistochemical
markers
Paraganglioma Typical carcinoid Atypical carcinoid Small cell neuroendocrine tumor MTC FTC
1.Neuro-specific enolase (+) (+) (+) (+) (+) (−)
2.Chromogranin A (+) (+) (+) (+) (+) (+)
3.Synaptophysin (+) (+) (+) (+) (+) (−)
4.Glial fibrillary acidic protein* (+) (−) (−) (−) (+) (−)
5.S-100 protein* (+) (−) (−) (−) (−) (−)
6.Cytokeratin (−) (+) (+) (+) (+) (+)
7.Calcitonin (−) (+) (+) (+)/(−) (+) (+)
8.CEA (−) (+) (+) (+) (+) (+)
9.EMA (−) (+) (+) (+) (+) (+)
10. TTF1 (−) (−) (−) (+)/(−) (+) (+)
11. MIB-1 (−) (−) (−) (−) (−) (+)

MTC medullary thyroid carcinoma; FTC follicular thyroid carcinoma; CEA carcinoembryonic antigen; EMA epithelial membrane antigen; TTF-1 thyroid transcription factor 1; MIB-1 molecular immunology Borstel number 1

*Positivity only in the sustentacular cells